uniQure
Meibergdreef 61
Amsterdam
1105 BA
Tel: 31-20-566-7394
Fax: 31-20-566-9272
Website: http://www.uniqure.com/
Email: info@uniQure.com
203 articles about uniQure
-
uniQure Announces Financial Results For Second Quarter 2016 And Update On Company Progress
8/26/2016
-
uniQure To Present At Upcoming Investor Conferences In September
8/17/2016
-
Shire Kills Baxalta's Hemophilia B Program; Clears Path for BioMarin, Spark Therapeutics and uniQure
8/4/2016
-
uniQure Presents Updated Clinical Data In Patients With Severe Hemophilia B Demonstrating Up To 9 Months Of Sustained Levels Of Factor IX Activity And Therapeutic Effect
7/28/2016
-
uniQure Announces Oral Presentation Of Updated Results For AMT-060 At The World Federation Of Hemophilia (WFH) 2016 World Congress
7/11/2016
-
uniQure Appoints Jonathan Garen As Chief Business Officer
7/7/2016
-
Protein Sciences Corporation Announces Exclusive License To uniQure Of Cell Line And Technology For Production Of Human Gene Therapies
6/28/2016
-
uniQure Appoints Maria E. Cantor As Senior Vice President, Investor Relations & Communications
6/27/2016
-
uniQure Presents Clinical Data From Ongoing Phase I/II Study In Hemophilia B Demonstrating 6 Months Of Sustained Increases In Factor IX Activity
6/13/2016
-
uniQure Announces Results For First Quarter 2016
5/31/2016
-
uniQure Announces Oral Presentation Of Clinical Data From Ongoing Phase I/II Study Of AMT-060 In Hemophilia B At The 21st Congress Of The European Hematology Association
5/19/2016
-
uniQure Announces Oral Presentation Of Clinical Data From Ongoing Phase I/II Study Of AMT-060 In Hemophilia B At The 21st Congress Of The European Hematology Association
5/19/2016
-
uniQure To Present At Upcoming Investor Conferences In New York City
5/12/2016
-
uniQure Announces The Nomination Of Jack Kaye To Its Board Of Directors And Proposed Corporate Governance Changes
5/10/2016
-
uniQure Presents Preclinical Data On AAV Re-Administration, Regulated Gene Expression And Total Brain Transduction At ASGCT
5/9/2016
-
uniQure Appoints Paul Firuta As Chief Commercial Officer
5/3/2016
-
uniQure To Present Data On Gene Therapy Technology Advances At Annual Meeting Of The American Society Of Gene And Cell Therapy
4/20/2016
-
uniQure To Present Data On Gene Therapy Technology Advances At Annual Meeting Of The American Society Of Gene And Cell Therapy
4/19/2016
-
uniQure Announces Results For Fourth Quarter And Financial Year 2015
4/4/2016
-
uniQure Announces Preclinical Proof Of Concept For Gene Therapy Approach In Huntington's Disease
3/23/2016